Ізраїль - іврит - Ministry of Health

rafa laboratories ltd - prednisone 1 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness

Ізраїль - іврит - Ministry of Health

rafa laboratories ltd - prednisone 1 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness

Ізраїль - іврит - Ministry of Health

rafa laboratories ltd - prednisone 2 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness

Ізраїль - іврит - Ministry of Health

rafa laboratories ltd - prednisone 2 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness

Ізраїль - іврит - Ministry of Health

rafa laboratories ltd - prednisone 5 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness

Ізраїль - іврит - Ministry of Health

rafa laboratories ltd - prednisone 5 mg - tablets modified release - prednisone - for the treatment of moderate to severe, active rheumatoid arthritis in adults particularly when accompanied by morning stiffness

Ізраїль - іврит - Ministry of Health

abic marketing ltd, israel - ampicillin as sodium - אבקה להמסה להזרקה\אינפוזיה - ampicillin as sodium 1 g/vial - ampicillin - ampicillin - penibrin injection is recommended in serious infections when prompt, effective levels of the antibiotic must reach the site of infection. such infections include meningitis, subacute bacterial endocarditis, peritonitis, septicemia, severe forms of chronic bronchitis, osteomyelitis, pneumonia and pyelonephritis due to susceptible organisms.

Ізраїль - іврит - Ministry of Health

abic marketing ltd, israel - ampicillin as sodium - אבקה להמסה להזרקה\אינפוזיה - ampicillin as sodium 2 g/vial - ampicillin - ampicillin - penibrin injection is recommended in serious infections when prompt, effective levels of the antibiotic must reach the site of infection. such infections include meningitis, subacute bacterial endocarditis, peritonitis, septicemia, severe forms of chronic bronchitis, osteomyelitis, pneumonia and pyelonephritis due to susceptible organisms.

Ізраїль - іврит - Ministry of Health

megapharm ltd - cyclophosphamide - אבקה להכנת תמיסה לזריקה - cyclophosphamide 500 mg/vial - cyclophosphamide - cyclophosphamide - malignant diseases: cycophosphamide although effective alone in susceptible melignancies is more frequently used concurrently or sequentially with other antineoplastic drugs. the following malignancies are often susceptible. cycophosphamide treatment: 1) malignant lymphomas (stages iii and iv of the ann arbor staging system) hodgkin`s disease lymphocytic lymphoma (nodular or diffuse) mixed-cell type lymphoma histiocytic lymphoma burkitt`s lymphoma. 2) multiple myeloma. 3) leukemias: chronic lymphocytic leukemia chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis) acute myelogenous and monocytic leukemia acute lymphoblastic (stemcell) leukemia in children. 4) mycosis fungoides (advenced disease). 5) neuroblastoma (disseminated disease). 6) adenocarcinoma of the ovary. 7) retinoblastoma. 8) carcinoma of the breast. nonmallgnant disease biopsy proven "minimal change" nephrotic syndrome in children whose disease fails to respond adequately to another treatment. severe cases of systemi

Ізраїль - іврит - Ministry of Health

megapharm ltd - cyclophosphamide - אבקה להכנת תמיסה לזריקה - cyclophosphamide 1 g/vial - cyclophosphamide - cyclophosphamide - malignant diseases: cycophosphamide although effective alone in susceptible melignancies is more frequently used concurrently or sequentially with other antineoplastic drugs. the following malignancies are often susceptible. cycophosphamide treatment: 1) malignant lymphomas (stages iii and iv of the ann arbor staging system) hodgkin`s disease lymphocytic lymphoma (nodular or diffuse) mixed-cell type lymphoma histiocytic lymphoma burkitt`s lymphoma. 2) multiple myeloma. 3) leukemias: chronic lymphocytic leukemia chronic granulocytic leukemia (it is usually ineffective in acute blastic crisis) acute myelogenous and monocytic leukemia acute lymphoblastic (stemcell) leukemia in children. 4) mycosis fungoides (advenced disease). 5) neuroblastoma (disseminated disease). 6) adenocarcinoma of the ovary. 7) retinoblastoma. 8) carcinoma of the breast. nonmallgnant disease biopsy proven "minimal change" nephrotic syndrome in children whose disease fails to respond adequately to another treatment. severe cases of systemi